Fasting hyperinsulinemia in human immunodeficiency virus-infected men: Relationship to body composition, gonadal function, and protease inhibitor use

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 35-41

  Hadigan, Colleen ^a   Corcoran, Colleen ^a   Stanley, Takara ^a   Piecuch, Sarah ^a   Klibanski, Anne ^a   Grinspoon, Steven ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INSULIN; PLACEBO; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GONAD FUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERINSULINEMIA; HYPOGONADISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WASTING SYNDROME;

ADIPOSE TISSUE; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY COMPOSITION; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; PHENOTYPE; TESTOSTERONE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034457359     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.35     Document Type: Article

References (26)

1. Diagnosis, prediction, and natural course of HW-1 protease-inhibitor associated lipodystrophy, hyperlipidemia and diabetes mellitus: A cohort study
2. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study
3. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1 infected patients
4. Visceral abdominal-fat accumulation associated with use of indinavir
5. Fasting hyperinsulinemia and changes in regional body composition in hivinfected women
6. Endocrine disorders in men infected with human immunodeficiency virus
7. Effects of testosterone replacement with a nongeintal, transdermal system, Androderm, in human immunodeficiency-virus infected men with low testosterone levels
8. Effects of androgen administration in men with AIDS wasting: A randomized, placebo-controlled, trial
9. Sustained anabolic effects of long-term androgen administration in men with AiDS wasting
10. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men
11. Visceral fat accumulation in men is positively associated with insulin, glucose, and Cpeptide levels, but negatively with testosterone levels
12. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men
13. Loss of leanbody mass and muscle mass correlates with androgen levels in hypogonadal men with acquired immumodeficiency syndrome and wasting
14. Quantitative assessment of cross-sectional muscle area, functional status and muscle strength in men with the AIDS wasting syndrome
15. Effects of androgen administration on the GH-IGF-I axis in men with AiDS wasting
16. Case records of the Massachusetts General Hospital. 1992 Weekly clinicopathological exercises. Normal reference laboratory values
17. A prospective analysis of the HOMA model: The Mexico City diabetes study
18. Metropolitan height and weight tables
19. Pathogenesis of HW-l-proteaseinhibitor-associated peripheral lipodystrophy, hyperlipidenmia and insulin resistance
20. Evaluation of abdominal fat distribution in non insulin dependent diabetes mellitus: Relationship to insulin resistance
21. Testicular dysfunction in human immunodeficiency virus-infected patients
22. Testosterone administration to normal men decreases truncal and total body fat
23. Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man
24. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
25. Elevated serum lipids in hypogonadal men with and without hyperprolactinemia
26. Effects of gonadotropin and testosterone treatments on lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism